Zarontin (Parke-Davis Div of Pfizer Inc)


Welcome to the PulseAid listing for the Zarontin drug offered from Parke-Davis Div of Pfizer Inc. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Parke-Davis Div of Pfizer Inc
NON-PROPRIETARY NAME: Ethosuximide
SUBSTANCE NAME: ETHOSUXIMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
ROUTE: ORAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2002-02-27
END MARKETING DATE: 0000-00-00


Zarontin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZarontin from Parke-Davis Div of Pfizer Inc
LABELER NAME: Parke-Davis Div of Pfizer Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/5mL)
START MARKETING DATE: 2002-02-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0071-2418_db4f89ce-62a4-41de-91d0-fe691c7b38ba
PRODUCT NDC: 0071-2418
APPLICATION NUMBER: ANDA080258

Other ETHOSUXIMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalEthosuximide
Banner Life Sciences LLC.Ethosuximide
Bionpharma Inc.Ethosuximide
Greenstone LLCEthosuximide
Heritage Pharmaceuticals Inc.ETHOSUXIMIDE
Mikart, Inc.ethosuximide
Parke-Davis Div of Pfizer IncZarontin
Pharmaceutical Associates, Inc.ETHOSUXIMIDE
Pliva Inc.Ethosuximide
Teva Pharmaceuticals USA, Inc.Ethosuximide
VersaPharm IncorporatedEthosuximide
Zydus Pharmaceuticals (USA) Inc.ethosuximide